Intellia Therapeutics, Inc.

0JBU.L·LSE
Compare
10.20+0.98 (+10.63%)today
At close: Nov 20, 7:09 PM GMT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.

Key statistics

Previous close9.22
Open9.38
Day range9.2710.38
52-week range7.9119.20
Off day high−1.73%
Off 52-week high−46.88%
Volume36.76K
Avg. volume (3M)20.66K
Market cap—
EPS (TTM)-5.06
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.82
Shares outstanding43.42M
Short interest—
Earnings date—
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
0JBU.L CRSP EDIT DTIL SCTX PRQR
Market cap — 3.79B 253.12M 282.46M 228.58M 146.98M
P/E (TTM) — — — 29.6 — —
Forward P/E — -10.6 -2.3 -3.4 -3.6 -2.3
Price/book 2.3 2.3 3.0 4.0 1.8 2.0
Dividend yield — — — — — —
1-year change +11.61% −22.50% −29.34% +38.20% −30.31% −52.73%
Today +10.63% +0.44% −4.09% +7.09% −8.70% −0.95%

The closest companies by business. Prices may be delayed up to 15 min.

Latest news

All 0JBU.L news ›
markets.businessinsider.com·Positive

Intellia Therapeutics (NTLA) Receives a Buy from Canaccord Genuity

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Intellia Therapeutics on November 13 and set a price target of $49.00. The company’s shares closed last Friday at $9.70. According to TipRanks, Ijem is a 5-star analyst with…

BioSpace··2 outletsPositive

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 6, 2026

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

31mentions in 30 days
31with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 31 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance